166 related articles for article (PubMed ID: 38568469)
21. Hereditary gene mutations in Korean patients with isolated erythrocytosis.
Jang JH; Seo JY; Jang J; Jung CW; Lee KO; Kim SH; Kim HJ
Ann Hematol; 2014 Jun; 93(6):931-5. PubMed ID: 24482100
[TBL] [Abstract][Full Text] [Related]
22. Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR.
Wang Z; Tian X; Ma J; Zhang Y; Ta W; Duan Y; Li F; Zhang H; Chen L; Yang S; Liu E; Lin Y; Yuan W; Ru K; Bai J
Cancer Med; 2024 Apr; 13(7):e7123. PubMed ID: 38618943
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.
Agarwal R; Blombery P; McBean M; Jones K; Fellowes A; Doig K; Forsyth C; Westerman DA
Ann Hematol; 2017 May; 96(5):725-732. PubMed ID: 28161773
[TBL] [Abstract][Full Text] [Related]
24. Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F- and MPLW515 L-positive myelofibrosis.
Schulze S; Stengel R; Jaekel N; Wang SY; Franke GN; Roskos M; Schneider M; Niederwieser D; Al-Ali HK
Genes Chromosomes Cancer; 2019 Nov; 58(11):747-755. PubMed ID: 31135094
[TBL] [Abstract][Full Text] [Related]
25. The complete evaluation of erythrocytosis: congenital and acquired.
Patnaik MM; Tefferi A
Leukemia; 2009 May; 23(5):834-44. PubMed ID: 19295544
[TBL] [Abstract][Full Text] [Related]
26. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.
Tefferi A; Pardanani A
Mayo Clin Proc; 2007 May; 82(5):599-604. PubMed ID: 17493421
[TBL] [Abstract][Full Text] [Related]
28. The clinical and laboratory evaluation of the patient with erythrocytosis.
Lee G; Arcasoy MO
Eur J Intern Med; 2015 Jun; 26(5):297-302. PubMed ID: 25837692
[TBL] [Abstract][Full Text] [Related]
29. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.
Mori Y; Araki M; Morishita S; Imai M; Edahiro Y; Ito M; Ochiai T; Shirane S; Hashimoto Y; Yasuda H; Ando J; Ando M; Komatsu N
Cancer Med; 2023 Jan; 12(2):1079-1089. PubMed ID: 35775283
[TBL] [Abstract][Full Text] [Related]
31. Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
Sultan S; Irfan SM; Khan SR
Asian Pac J Cancer Prev; 2016; 17(3):1053-5. PubMed ID: 27039724
[TBL] [Abstract][Full Text] [Related]
32. Hereditary erythrocytosis, thrombocytosis and neutrophilia.
Hong WJ; Gotlib J
Best Pract Res Clin Haematol; 2014 Jun; 27(2):95-106. PubMed ID: 25189721
[TBL] [Abstract][Full Text] [Related]
33. Genetic basis of unexplained erythrocytosis in Indian patients.
Mallik N; Sharma P; Kaur Hira J; Chhabra S; Sreedharanunni S; Kumar N; Naseem S; Sachdeva MUS; Ahluwalia J; Malhotra P; Varma N; Varma S; Das R
Eur J Haematol; 2019 Aug; 103(2):124-130. PubMed ID: 31132167
[TBL] [Abstract][Full Text] [Related]
34. Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation.
Bernardi M; Ruggeri M; Albiero E; Madeo D; Rodeghiero F
Am J Hematol; 2009 Apr; 84(4):258-60. PubMed ID: 19229983
[No Abstract] [Full Text] [Related]
35. Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review.
Chin-Yee B; Matyashin M; Cheong I; Bhai P; Lazo-Langner A; Almanaseer A; Kawata E; Levy MA; Stuart A; Lin H; Chin-Yee I; Sadikovic B; Hsia C
CMAJ Open; 2022; 10(4):E988-E992. PubMed ID: 36347562
[TBL] [Abstract][Full Text] [Related]
36. Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.
Ohyashiki JH; Hisatomi H; Shimizu S; Sugaya M; Ohyashiki K
Jpn J Clin Oncol; 2009 Aug; 39(8):509-13. PubMed ID: 19491085
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis-associated genes in the Slovenian family with idiopathic erythrocytosis.
Kristan A; Gašperšič J; Režen T; Kunej T; Količ R; Vuga A; Fink M; Žula Š; Anžej Doma S; Preložnik Zupan I; Pajič T; Podgornik H; Debeljak N
J Clin Lab Anal; 2021 Apr; 35(4):e23715. PubMed ID: 33534944
[TBL] [Abstract][Full Text] [Related]
38. Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.
Li SD; Ma M; Li H; Waluszko A; Sidorenko T; Schadt EE; Zhang DY; Chen R; Ye F
Genome Med; 2017 Oct; 9(1):89. PubMed ID: 29082853
[TBL] [Abstract][Full Text] [Related]
39. rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
Remenyi G; Bereczky Z; Gindele R; Ujfalusi A; Illes A; Udvardy M
Pathol Oncol Res; 2021; 27():1609987. PubMed ID: 34899081
[TBL] [Abstract][Full Text] [Related]
40. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
